Sort   by:  
 Page size 
UnknownIncreasing Insurance Choices In The Affordable Care Act Marketplaces, 2018-21.
Not available
S-EPMC8702244 | biostudies-literature
TranscriptomicsTranscription profiling of Francisella tularensis mutants to identify gene required for Francisella virulence
pool 16 and pool 29 arrays represent the Francisella transposon insertion mutants isolated from the spleens of two separate groups of 5 intraperitoneally infected mice. skin arrays represent the Francisella transposon insertion mutants isolated from the skin of 5 individual, subcutaneously infected...
ORGANISM(S): Francisella tularensis 
2007-05-02 | E-SMDB-3978 | biostudies-arrayexpress
OtherMixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency.
Data from ProteomeXchange, PXD ID: PXD002150. File: 14july14_saha_b_65.mzml. Published as part of Antiviral Res. 2015 Sep 3. pii: S0166-3542(15)00213-2 . From the Abstract: {{i}} ... We therefore utilized a combined analysis of effects of SAHA on the host transcriptome and proteome to dissect its m...
ORGANISM(S): Homo_sapiens_viruses, Human 
GPM32310023592 | GPMDB
Resource Reanalysis 
UnknownAssociation Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
Not available
S-EPMC10469105 | biostudies-literature
TranscriptomicsIndices of Tolerance (IOT): Cross-platform biomarkers that identify kidney transplant tolerance
Being able to identify patients in whom immunological tolerance has been established or is developing would allow an individually tailored approach to post-transplant management of kidney allograft recipients. Ex vivo immunological monitoring was performed on samples from five groups of European ren...
ORGANISM(S): Homo sapiens 
2010-05-25 | E-GEOD-14655 | biostudies-arrayexpress
UnknownViral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.
Not available
S-EPMC11793053 | biostudies-literature
UnknownPost-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Not available
S-EPMC11381616 | biostudies-literature
UnknownOutcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
Not available
S-EPMC4624003 | biostudies-literature
UnknownMapping the genetic landscape across 14 psychiatric disorders.
Not available
S-EPMC12779569 | biostudies-literature
UnknownA Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries.
Not available
S-EPMC7421468 | biostudies-literature
Sort   by:  
 Page size